Attribution Assumption Set

Select a scenario or drag the sliders below to customize. Only connector-related CLABSIs are attributed to QIKcap.

Conservative

18%

30% connector × 60% reduction

Moderate

26%

40% connector × 65% reduction

Aggressive

35%

50% connector × 70% reduction

Attributable Reduction Formula

40% connector-related CLABSIs × 65% QIKcap reduction = 26% total CLABSI reduction attributed to QIKcap

~30–50% of CLABSIs are hub/connector-related (Safdar et al. CID 2002; Mermel CID 2011). Passive cap RCTs show 50–60% reduction in those events; QIKcap's active UV-C + verified compliance supports 60–70%.

Connector-Related CLABSI %literature: 30–50%

40%

10%60%

QIKcap Reduction of Those Eventsliterature: 50–70%

65%

30%85%

Your Annual Cost

$1,780

20 beds × $89 × 12 months

Unlimited cap usage included

→

Estimated Savings

Direct cost + LOS recovery

Net Return:

Net savings as enrolled beds scale up ↓

0 beds▲ you are here400 beds

Your Facility Parameters

Hospital Beds Enrolleddrives your cost

20beds

5500

Baseline CLABSI Rate

1.0per 1,000 CL-days

0.55.0

Monthly Subscription

CLABSIs Prevented

0.0

Effective Reduction

Direct Cost Avoided

$48,108 per CLABSI (AHRQ)

Return on Investment

Breakeven Point

0.00

CLABSIs prevented covers full annual cost

♻️ Premium Cap Recycle Service

```

Add Premium Disposable Cap Recycle Service

Reduces medical waste, landfill burden & hospital carbon footprint

+$10/bed/mo

```

🛡

Built to Survive VAC Scrutiny

These estimates credit QIKcap only for CLABSIs caused by contaminated IV connectors — roughly 30–50% of all CLABSIs — not the full bundle effect. The standard tier delivers $1.10 returned per $1 spent at conservative assumptions (rate 0.5). Adding the Premium Recycle service reduces that return by $0.01 to $1.09 per $1 spent — a negligible tradeoff for a measurable reduction in medical waste and carbon footprint. Moderate and aggressive scenarios scale proportionally above both floors.

ASSUMPTIONS & REFERENCES

CLABSI Attribution
[1] Safdar N, Kluger DM, Maki DG. "A review of risk factors for catheter-related bloodstream infection caused by percutaneously inserted, noncuffed central venous catheters." Medicine 2002;81(6):466–479. (30–50% of CLABSIs are hub/connector-origin.)
[2] Mermel LA. "What is the predominant source of intravascular catheter infections?" Clin Infect Dis 2011;52(2):211–212.

Disinfection Cap Efficacy
[3] Ramirez C, et al. "Reduction of healthcare-associated infections using passive disinfection caps." Am J Infect Control 2010. (50–60% reduction in connector-related events.)
[4] Sweet MA, et al. "Impact of alcohol-impregnated port protectors and needleless neutral pressure connectors on central line-associated bloodstream infections." Infect Control Hosp Epidemiol 2012;33(6):645–648.

CLABSI Cost & Length of Stay
[5] Agency for Healthcare Research and Quality (AHRQ). Saving Lives and Saving Money: Hospital-Acquired Conditions Update. 2019. ($48,108 attributable cost per CLABSI.)
[6] Laguio-Vila M, et al. "Excess length of stay attributable to central line-associated bloodstream infections." Presented at IDSA Annual Meeting 2023. (13.4 excess hospital days per CLABSI.)
[7] Length of stay cost estimated at $2,500/day (AHRQ national inpatient cost benchmarks).

Green / Recycle Program
[8] U.S. EPA. Waste Reduction Model (WARM). Version 15, 2019. (Plastics landfill vs. recycling CO₂e factors.)
[9] Practice Greenhealth. Sustainability Benchmark Report. 2022. (Medical-grade plastic disposal cost range $0.08–$0.18/unit; hospital carbon cost $45–$65/tonne CO₂e.)
[10] U.S. EPA GHG Equivalencies Calculator. 1 tonne CO₂ ≈ 12 trees grown for 10 years; ≈ 2,481 miles driven (404g CO₂/mile avg passenger vehicle); ≈ 550 kWh electricity consumed. QIKcap™ cap weight: 0.5g polypropylene; CO₂e factor: 0.0015 kg/cap (polypropylene manufacturing ~3 kg CO₂/kg resin, EPA AP-42).

Pricing
QIKcap™ standard subscription: $89/bed/month, unlimited caps • Premium Cap Recycle Service: $99/bed/month • FDA De Novo clearance granted December 30, 2025 (DEN250004) — first UV-C-based microbial reduction device cleared for luer-activated valves.

QIKcap™ Savings Calculator